Provider 1366559064
NPI: 1366559064Share
Active Billing Period:2018-01→2024-11(83 months)
Extreme procedure concentration — 100% of $16.9M billed through a single code
Total Paid
$16.9M
$16,901,442
Total Claims
5,644
Beneficiaries
3,155
1.8 claims/patient
Avg Cost/Claim
$3K
Monthly Spending Trend
Yearly Spending
2018
$2.3M
-30%
2019
$1.6M
+45%
2020
$2.3M
-20%
2021
$1.9M
+32%
2022
$2.5M
+24%
2023
$3.1M
+8%
2024
$3.3M
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 1 distinct procedure code. The top code (Q5003 (Injection, infliximab-dyyb, biosimilar, 10 mg)) accounts for 100% of total spending.
ProcedureTotalYour Cost/ClaimNational Medianvs MedianPercentile
$16.9M
5,644 claims
$2,994.59
$177.99
16.8×
Top 25%
Q5003Top 25%
Injection, infliximab-dyyb, biosimilar, 10 mg
$16.9M
5,644 claims · 100.0%
Your Cost: $2,994.59/claim|Median: $177.99
16.8× median